Stella M. Robertson

Dr. Robertson, Co-Founder, and Partner of Bios Partners, has over 35 years of experience in pharmaceutical research and development, including R&D strategies, project management, clinical trials, regulatory filings, product launch, market support, translational medicine, and medical communication.

Dr. Robertson is a member and investor with Cowtown Angels and the owner of Arrochar Consulting LLC. She formerly was a Vice President in Research and Development at Alcon Laboratories, Inc., where she grew and led organizations that were responsible for the ophthalmic pipeline, otic pharmaceuticals, and medical devices. During her tenure at Alcon, she and her colleagues successfully developed, registered, and globally launched sixteen ophthalmic medications, as well as treatments for otitis media and nasal allergy.

Dr. Robertson received a Ph.D. in Biology-Immunology from Johns Hopkins University, was an Arthritis Foundation post-doctoral research fellow at UTHSC Dallas, and completed the Program for Management Development at Harvard Business School. She volunteers with the University of North Texas Health Science Center entrepreneurial program and as an adjunct for the Ophthalmology Department of UT Southwestern Medical School. She currently serves on the boards of early-stage companies Azitra, Trefoil Therapeutics, and AyuVis Research, as well as the Association for Research in Vision and Ophthalmology (ARVO) Foundation and the non-profit incubator TECH Fort Worth.